Cargando…
Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome
Monitoring minimal residual disease (MRD) provides important information during treatment of hematologic malignancies. Chimerism analysis also provides key information after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recent advances in next-generation sequencing (NGS) have enabl...
Autores principales: | Lee, Jong-Mi, Kim, Yoo-Jin, Park, Sung-Soo, Han, Eunhee, Kim, Myungshin, Kim, Yonggoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947461/ https://www.ncbi.nlm.nih.gov/pubmed/31795155 http://dx.doi.org/10.3390/jcm8122077 |
Ejemplares similares
-
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era
por: Lee, Jong-Mi, et al.
Publicado: (2021) -
FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
por: Lee, Jong-Mi, et al.
Publicado: (2022) -
Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016) -
Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Kim, Hee-Je, et al.
Publicado: (2021) -
Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
por: Yoo, Jaeeun, et al.
Publicado: (2020)